Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic Agents
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: gemcitabine|DRUG: capecitabine|DRUG: docetaxel
Sponsor: Eli Lilly and Company